| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.63▼ | 3.54▲ | 3.54▲ | 3.40▲ | 3.42▲ |
| MA10 | 3.42▲ | 3.41▲ | 3.41▲ | 3.38▲ | 3.40▲ |
| MA20 | 3.38▲ | 3.44▲ | 3.46▲ | 3.45▲ | 3.39▲ |
| MA50 | 3.49▲ | 3.49▲ | 3.47▲ | 3.41▲ | 4.07▼ |
| MA100 | 3.46▲ | 3.43▲ | 3.40▲ | 3.39▲ | 3.18▲ |
| MA200 | 3.38▲ | 3.67▼ | 3.76▼ | 4.03▼ | 3.26▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.046▲ | 0.032▲ | 0.027▲ | 0.013▲ | 0.037▲ |
| RSI | 55.732▲ | 54.266▲ | 53.681▲ | 57.412▲ | 50.432▲ |
| STOCH | 75.694 | 59.028 | 59.028 | 45.902 | 49.885 |
| WILL %R | -29.167 | -29.167 | -29.167 | -13.903▲ | -23.330▲ |
| CCI | 58.163 | 72.665 | 71.316 | 117.056▲ | 115.991▲ |
|
Monday, March 30, 2026 07:37 AM
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing ...
|
|
Monday, March 30, 2026 04:49 AM
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...
|
|
Sunday, March 29, 2026 05:38 AM
Mar 2026 - Alignment reached on key elements of ATH434 Phase 3 development program for Multiple System Atrophy ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/04/26 | 3.5648 | 3.67 | 3.50 | 3.6362 | 4,453 |
| 31/03/26 | 3.41 | 3.57 | 3.41 | 3.48 | 4,457 |
| 30/03/26 | 3.30 | 3.7244 | 3.29 | 3.57 | 94,715 |
| 27/03/26 | 3.09 | 3.2678 | 3.09 | 3.16 | 4,796 |
| 26/03/26 | 3.38 | 3.39 | 3.16 | 3.16 | 9,334 |
| 25/03/26 | 3.35 | 3.4101 | 3.35 | 3.41 | 3,176 |
| 24/03/26 | 3.34 | 3.40 | 3.33 | 3.33 | 6,036 |
| 23/03/26 | 3.27 | 3.48 | 3.27 | 3.30 | 1,566 |
| 20/03/26 | 3.49 | 3.49 | 3.275 | 3.29 | 10,522 |
| 19/03/26 | 3.31 | 3.45 | 3.31 | 3.45 | 1,455 |
|
|
||||
|
|
||||
|
|